Evidence map›Paper›PMID 42087992›Full record

ArticleVirus evolution2026

Peaked-to-flat transition in quasispecies structure evolution.

Josep Gregori, Sergi Colomer-Castell, Carolina Campos, Marta Ibañez-Lligoña, Damir García-Cehic, Maria Francesca Cortese, David Tabernero, Mar Riveiro-Barciela, Maria Buti, Ariadna Rando-Segura and 7 more

Abstract read
In one paragraph

Article in Virus evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Josep GregoriLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-4253-8015
Sergi Colomer-CastellLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-0307-7455
Carolina CamposLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-0132-7027
Marta Ibañez-LligoñaLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0003-3428-2168
Damir García-CehicCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID https://orcid.org/0000-0002-0009-038X
Maria Francesca CorteseCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID https://orcid.org/0000-0002-4318-532X
David TaberneroLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-1146-4084
Mar Riveiro-BarcielaLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0001-9309-2052
Maria ButiLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-0732-3078
Ariadna Rando-SeguraCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID https://orcid.org/0000-0003-4555-7286
Roser FerrerBiochemistry Department, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0002-8925-3172
Tomàs PumarolaBiochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça Cívica, 08193 Bellaterra, Spain.ORCID https://orcid.org/0000-0002-5171-7461
Cristina AndrésBiochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça Cívica, 08193 Bellaterra, Spain.ORCID https://orcid.org/0000-0002-3200-0895
Alejandra González-SánchezBiochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça Cívica, 08193 Bellaterra, Spain.ORCID https://orcid.org/0000-0002-1809-3415
Andrés AntónBiochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça Cívica, 08193 Bellaterra, Spain.ORCID https://orcid.org/0000-0002-1476-0815
Francisco Rodriguez-FriasCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID https://orcid.org/0000-0002-9128-7013
Josep QuerLiver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.ORCID https://orcid.org/0000-0003-0014-084X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies based on clinical data from hepatitis C virus and hepatitis E virus infections revealed a deterministic evolution of quasispecies structure, irrespective of haplotype identities, towards a flat-like landscape, characterized by the absence of dominance and high evenness, combined with high haplotype synonymy. Here, two idealized limiting quasispecies states, A and Z, are defined, and it is shown that the A-to-Z evolution describes a parabolic trajectory between these states. The initial phase is dominated by increasing genetic diversity, whereas the subsequent phase is driven primarily by increasing evenness in the haplotype distribution. This evolutionary progression confers a broad domain within the genetic space, resulting in increased fitness and resilience, accompanied by a diminished response to antiviral therapies and multiple escape routes. Finally, a normalized quasispecies maturity score is proposed to position a given quasispecies along this structural evolutionary trajectory. This conceptual framework helps to account for the challenges in treating advanced chronic infections in which therapeutic failure frequently occurs in the absence of resistance-associated mutations.

Indexed as

antiviral resistancediversityevennesshaplotype synonymymaturity scorequasispecies structureviral quasispecies

Identifiers

PMID42087992
PMCPMC13137331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.